Evidence map›Paper›PMID 19875556›Full record

ReviewDiabetes care2009

Incretin-based therapies: viewpoints on the way to consensus.

Michael A Nauck, Tina Vilsbøll, Baptist Gallwitz, Alan Garber, Sten Madsbad

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetes care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07590219 (Efficacy, Metabolic and Cardiovascular Effects of Liraglutide in Children Aged 6-12 Years With Severe Obesity), which is not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07590219 phase4active not recruitingstarted 2024, after this paper: background citation

Efficacy, Metabolic and Cardiovascular Effects of Liraglutide in Children Aged 6-12 Years With Severe Obesity: A Randomized Controlled Trial With Advanced Echocardiographic Assessment

Ran2024Enrolled30Registered outcomes9Posted comparisons0ConditionsCardiovascular Function, Childhood Obesity, Echocardiography, LiraglutideArmsLiraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
PMID 27295427PMID 38438626PMID 28359099PMID 23449553PMID 23302619PMID 8610077PMID 9614255PMID 29055731PMID 31963569PMID 32233338PMID 36322838other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Regulatory mechanisms of the green algaCurrent research in food science · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael A NauckDiabetes Center Bad Lauterberg, Bad Lauterberg im Harz, Germany. m.nauck@diabeteszentrum.de
Tina Vilsbøll
Baptist Gallwitz
Alan Garber
Sten Madsbad

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsDiabetes MellitusDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHumansHypoglycemiaHypoglycemic AgentsIncretinsInsulin-Secreting CellsReceptors, GlucagonDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsDPP4 protein, humanGLP1R protein, humanGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHypoglycemic AgentsIncretinsReceptors, Glucagon

Identifiers

PMID19875556
PMCPMC2811437

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.